Cargando…
Long‐term effects of an oral elemental nutritional supplement on post‐gastrectomy body weight loss in gastric cancer patients (KSES002)
AIM: The present study aimed to evaluate the efficacy of short‐term nutritional intervention with an oral elemental diet (ED; Elental; EA Pharma Co., Ltd, Tokyo, Japan) at 300 kcal/day for 6‐8 weeks in the early post‐gastrectomy period on postoperative long‐term body weight loss (BWL). METHODS: We a...
Autores principales: | Kimura, Yutaka, Nishikawa, Kazuhiro, Kishi, Kentaro, Inoue, Kentaro, Matsuyama, Jin, Akamaru, Yusuke, Tamura, Shigeyuki, Kawada, Junji, Kawase, Tomono, Kawabata, Ryohei, Fujiwara, Yoshiyuki, Kanno, Hitoshi, Yamada, Takeshi, Shimokawa, Toshio, Imamura, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875942/ https://www.ncbi.nlm.nih.gov/pubmed/31788653 http://dx.doi.org/10.1002/ags3.12290 |
Ejemplares similares
-
Effects of an oral elemental nutritional supplement in gastric cancer patients with adjuvant S‐1 chemotherapy after gastrectomy: A multicenter, open‐label, single‐arm, prospective phase II study (OGSG1108)
por: Imamura, Hiroshi, et al.
Publicado: (2021) -
Real-world effectiveness of third- or later-line treatment in Japanese patients with HER2-positive, unresectable, recurrent or metastatic gastric cancer: a retrospective observational study
por: Sakai, Daisuke, et al.
Publicado: (2022) -
A phase II trial of dose-reduced nab-paclitaxel for patients with previously treated, advanced or recurrent gastric cancer (OGSG 1302)
por: Tamura, Shigeyuki, et al.
Publicado: (2020) -
Utility of monthly minodronate for osteoporosis after gastrectomy: Prospective multicenter randomized controlled trials
por: Hirota, Masashi, et al.
Publicado: (2021) -
Histology Classification Highlights Differences in Efficacy of S-1 versus Capecitabine, in Combination with Cisplatin, for HER2-Negative Unresectable Advanced or Recurrent Gastric Cancer with Measurable Disease
por: Kawakami, Hisato, et al.
Publicado: (2022)